Clinical trials query results
From Health Canada
- Medical condition:
- MALIGNANT PLEURAL MESOTHELIOMA
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- PEMETREXED/CISPLATIN/CARBOPLATIN
- Protocol title:
- PHASE III RANDOMIZED TRIAL OF PLEURECTOMY/DECORTICATION PLUS CHEMOTHERAPY WITH OR WITHOUT ADJUVANT HEMITHORACIC INTENSITY-MODULATED PLEURAL RADIATION THERAPY (IMPRINT) FOR MALIGNANT PLEURAL MESOTHELIOMA (MPM)
- Sponsor name:
- NRG ONCOLOGY
- Date of no objection letter:
- 2020-03-30
- Control number:
- 236052
- Trial status:
- CLOSED
- Date study completed:
- 2023-11-20